Impact of catalytic iron on mortality in patients with acute coronary syndrome exposed to iodinated radiocontrast - The Iscom Study

American Heart Journal

Volumn 165, Issue 5, 2013, Pages 744-751

  Lele, Suhas S ^a   Mukhopadhyay, Banibrata N ^b   Mardikar, Mohan M ^c   Patel, Tejas A ^d   Vasavada, Apoorva K ^e   Banker, Darshan N ^f   Kapasi, Ketan D ^a   Chauhan, Virendra C ^a   Chawla, Kamaldeep C ^g   Raju, Soma R ^e   Hiremath, Shirish S ^h   Chinchole, Sashi S ^b   Rajapurkar, Mohan M ^b  

^a Bhailal Amin General Hospital   (India)

^b MULJIBHAI PATEL UROLOGICAL HOSPITAL   (India)

^c Spandan Heart Institute and Research Center ^*  (India)

^d Department of Cardiology   (India)

^e Care Hospital Group   (India)

^f Bankers Heart Institute and Research Center   (India)

^g Sterling Hospital   (India)

^h Ruby Hall Clinic ^*  (India)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; IODINATED CONTRAST MEDIUM; IRON; TROPONIN;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CONTRAST INDUCED NEPHROPATHY; CORONARY ARTERY BYPASS GRAFT; CREATININE CLEARANCE; DIABETES MELLITUS; DISEASE DURATION; FEMALE; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; THORAX PAIN; TRANSLUMINAL CORONARY ANGIOPLASTY;

ACUTE CORONARY SYNDROME; ACUTE KIDNEY INJURY; CONTRAST MEDIA; CREATININE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDIA; IOHEXOL; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84876809204     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.02.016     Document Type: Article

References (28)

1. S.S. Lele, S. Shah, and P.M. McCoullough Serum Catalytic iron as a novel biomarker of vascular injury in acute coronary syndromes EuroIntervention 5 2009 336 342
2. Steen DL, Cannon CP, Lele SS, et al. Prognostic Evaluation of Catalytic Iron in Patients with Acute Coronary Syndromes. Abstract AHA 2012.
3. C.S. Rihal, S.C. Textor, and D.E. Grill Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention Circulation 105 2002 2259 2264
4. P.A. McCullough, and K.R. Sandberg Epidemiology of contrast-induced nephropathy Rev Cardiovasc Med 4 Suppl. 5 2003 S3 S9
5. L. Gruberg, G.S. Mintz, and R. Mehran The prognostic implications of further renal function deterioration within 48 h of intervention coronary procedures in patients with pre-existent chronic renal insufficiency J Am Coll Cardiol 36 2000 1542 1548
6. L. Gruberg, R. Mehran, and G. Dangas Acute renal failure requiring dialysis after percutaneous coronary interventions Catheter Cardiovasc Interv 52 2001 409 416
7. E.M. Levy, C.M. Viscoli, and R.I. Horwitz The effects of acute renal failure on mortality J Am Med Assoc 275 1996 1516 1517
8. P.A. McCullough, R. Wolyn, and L.L. Rocher Acute renal failure after coronary intervention: incidence, risk factor and relationship to mortality Am J Cardiol 103 1997 368 375
9. R. Mehran, and D.T. Ashby Radiocontrast-induced acute renal failure: allocations and outcomes Rev Cardiovasc Med 2 Suppl. 1 2001 S9 S13
10. P.J. Evans, and B. Halliwell Measurement of iron and copper in biological systems: bleomycin and copper-phenanthroline assays Methods Enzymol 233 1994 82 92
11. B. Halliwell, and J.M. Gutteridge Role of free radicals and catalytic metal ions in human disease: an overview Methods Enzymol 186 1990 1 85
12. K.J. Davies An overview of oxidative stress IUBMB Life 50 2000 241 244
13. R. Baliga, N. Ueda, and S.V. Shah Increase in bleomycin-detectable iron in ischaemia/reperfusion injury to rat kidneys Biochem J 291 Pt 3 1993 901 905
14. M.L. Circu, and T.Y. Aw Reactive oxygen species, cellular redox species and apoptosis Free Radic Biol Med 48 2010 749 762
15. W.A. Pryor, K. Stone, and L.Y. Zang Fractionation of aqueous cigarette tar extracts: fractions that contain the tar radical cause DNA damage Chem Res Toxicol 11 1998 441 448
16. A.K. Jacob, R.S. Hotchkiss, and S.L. DeMeester Endothelial cell apoptosis is accelerated by inorganic iron and heat via an oxygen radical dependent mechanism Surgery 122 1997 243 254
17. B. de Valk, and J.J. Marx Iron, atherosclerosis, and ischemic heart disease Arch Intern Med 159 1999 1542 1548
18. M.S. Paller, and H.S. Jacob Cytochrome P-450 mediates tissue-damaging hydroxyl radical formation during reoxygenation of the kidney Proc Natl Acad Sci U S A 91 1994 7002 7006
19. R. Baliga, Z. Zhang, and M. Baliga Evidence for cytochrome P-450 as a source of catalytic iron in myoglobinuric acute renal failure Kidney Int 49 1996 362 369
20. J.R. Pepper, S. Mumby, and J.M. Gutteridge Transient iron-overload with bleomycin-detectable iron present during cardiopulmonary bypass surgery Free Radic Res 21 1994 53 58
21. G. Sengoelge, V. Rainer, and J. Kletzmayr Dose-dependent effect of parenteral iron therapy on bleomycin-detectable iron in immune apheresis patients Kidney Int 66 2004 295 302
22. B. Lipinski Modification of fibrin structure as a possible cause of thrombolytic resistance J Thromb Thrombolysis 29 2010 296 298
23. A. Eckly, B. Hechler, and M. Freund Mechanisms underlying FeCl2-induced arterial thrombosis J Thromb Haemost 9 2011 779 789
24. G. Ambrosio, J.L. Zweier, and W.E. Jacobus Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury Circulation 76 4 1987 906 915
25. A.E. Say, M. Gursurer, and M.V. Yazicioglu Impact of body iron status on myocardial perfusion, left ventricular function, and angiographic morphologic features in patients with hypercholesterolemia Am Heart J 143 2 2002 257 264
26. G. Ndrepepa, S. Braun, and A. Dibra Iron status and clinical outcome in patients with coronary artery disease after coronary stenting Nutr Metab Cardiovasc Dis 15 6 2005 418 425 [Epub 2005 Jul 1]
27. I.A. Paraskevaidis, E.K. Iliodromitis, and D. Vlahakos Deferoxamine infusion during coronary artery bypass grafting ameliorates lipid peroxidation and protects the myocardium against reperfusion injury: immediate and long-term significance Eur Heart J 26 3 2005 263 270
28. R.S. Britton, K.L. Leicester, and B.R. Bacon Iron toxicity and chelation therapy Int J Hematol 76 2002 219 228